In the subgroups with obesity, we observed trends towards smaller responses to the glucagon infusion regarding some amino acids such as aspartic acid and valine, but overall, the effect of glucagon was similar in all groups with no clear effects of type 2 diabetes or obesity on the response to the high physiological glucagon levels. The gene discussed is GCG; the disease is type 2 diabetes mellitus.